These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
396 related articles for article (PubMed ID: 12958365)
1. Beta-arrestin 2 mediates endocytosis of type III TGF-beta receptor and down-regulation of its signaling. Chen W; Kirkbride KC; How T; Nelson CD; Mo J; Frederick JP; Wang XF; Lefkowitz RJ; Blobe GC Science; 2003 Sep; 301(5638):1394-7. PubMed ID: 12958365 [TBL] [Abstract][Full Text] [Related]
2. Dishevelled 2 recruits beta-arrestin 2 to mediate Wnt5A-stimulated endocytosis of Frizzled 4. Chen W; ten Berge D; Brown J; Ahn S; Hu LA; Miller WE; Caron MG; Barak LS; Nusse R; Lefkowitz RJ Science; 2003 Sep; 301(5638):1391-4. PubMed ID: 12958364 [TBL] [Abstract][Full Text] [Related]
3. Cell signaling. beta-arrestin--not just for G protein-coupled receptors. Spiegel A Science; 2003 Sep; 301(5638):1338-9. PubMed ID: 12958351 [No Abstract] [Full Text] [Related]
4. βarrestin2 interacts with TβRII to regulate Smad-dependent and Smad-independent signal transduction. McLean S; Bhattacharya M; Di Guglielmo GM Cell Signal; 2013 Jan; 25(1):319-31. PubMed ID: 23069267 [TBL] [Abstract][Full Text] [Related]
5. Differential responsiveness to autocrine and exogenous transforming growth factor (TGF) beta1 in cells with nonfunctional TGF-beta receptor type III. Deng X; Bellis S; Yan Z; Friedman E Cell Growth Differ; 1999 Jan; 10(1):11-8. PubMed ID: 9950213 [TBL] [Abstract][Full Text] [Related]
6. The type III transforming growth factor-beta receptor negatively regulates nuclear factor kappa B signaling through its interaction with beta-arrestin2. You HJ; How T; Blobe GC Carcinogenesis; 2009 Aug; 30(8):1281-7. PubMed ID: 19325136 [TBL] [Abstract][Full Text] [Related]
7. Molecular determinants underlying the formation of stable intracellular G protein-coupled receptor-beta-arrestin complexes after receptor endocytosis*. Oakley RH; Laporte SA; Holt JA; Barak LS; Caron MG J Biol Chem; 2001 Jun; 276(22):19452-60. PubMed ID: 11279203 [TBL] [Abstract][Full Text] [Related]
8. Association of beta-Arrestin 1 with the type 1A angiotensin II receptor involves phosphorylation of the receptor carboxyl terminus and correlates with receptor internalization. Qian H; Pipolo L; Thomas WG Mol Endocrinol; 2001 Oct; 15(10):1706-19. PubMed ID: 11579203 [TBL] [Abstract][Full Text] [Related]
9. A kinase subdomain of transforming growth factor-beta (TGF-beta) type I receptor determines the TGF-beta intracellular signaling specificity. Feng XH; Derynck R EMBO J; 1997 Jul; 16(13):3912-23. PubMed ID: 9233801 [TBL] [Abstract][Full Text] [Related]
10. Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor. Rotzer D; Roth M; Lutz M; Lindemann D; Sebald W; Knaus P EMBO J; 2001 Feb; 20(3):480-90. PubMed ID: 11157754 [TBL] [Abstract][Full Text] [Related]
11. A phosphorylation cluster of five serine and threonine residues in the C-terminus of the follicle-stimulating hormone receptor is important for desensitization but not for beta-arrestin-mediated ERK activation. Kara E; Crépieux P; Gauthier C; Martinat N; Piketty V; Guillou F; Reiter E Mol Endocrinol; 2006 Nov; 20(11):3014-26. PubMed ID: 16887887 [TBL] [Abstract][Full Text] [Related]
12. Stable interaction between beta-arrestin 2 and angiotensin type 1A receptor is required for beta-arrestin 2-mediated activation of extracellular signal-regulated kinases 1 and 2. Wei H; Ahn S; Barnes WG; Lefkowitz RJ J Biol Chem; 2004 Nov; 279(46):48255-61. PubMed ID: 15355986 [TBL] [Abstract][Full Text] [Related]
13. G-protein-coupled receptor (GPCR) kinase phosphorylation and beta-arrestin recruitment regulate the constitutive signaling activity of the human cytomegalovirus US28 GPCR. Miller WE; Houtz DA; Nelson CD; Kolattukudy PE; Lefkowitz RJ J Biol Chem; 2003 Jun; 278(24):21663-71. PubMed ID: 12668664 [TBL] [Abstract][Full Text] [Related]
14. ALK1 regulates the internalization of endoglin and the type III TGF-β receptor. Tazat K; Pomeraniec-Abudy L; Hector-Greene M; Szilágyi SS; Sharma S; Cai EM; Corona AL; Ehrlich M; Blobe GC; Henis YI Mol Biol Cell; 2021 Apr; 32(7):605-621. PubMed ID: 33566682 [TBL] [Abstract][Full Text] [Related]
15. In the absence of type III receptor, the transforming growth factor (TGF)-beta type II-B receptor requires the type I receptor to bind TGF-beta2. del Re E; Babitt JL; Pirani A; Schneyer AL; Lin HY J Biol Chem; 2004 May; 279(21):22765-72. PubMed ID: 14996829 [TBL] [Abstract][Full Text] [Related]
16. Transforming growth factor beta receptor signaling and endocytosis are linked through a COOH terminal activation motif in the type I receptor. Garamszegi N; Doré JJ; Penheiter SG; Edens M; Yao D; Leof EB Mol Biol Cell; 2001 Sep; 12(9):2881-93. PubMed ID: 11553725 [TBL] [Abstract][Full Text] [Related]
17. G-protein-coupled receptor kinase specificity for beta-arrestin recruitment to the beta2-adrenergic receptor revealed by fluorescence resonance energy transfer. Violin JD; Ren XR; Lefkowitz RJ J Biol Chem; 2006 Jul; 281(29):20577-88. PubMed ID: 16687412 [TBL] [Abstract][Full Text] [Related]
18. TβRIII independently binds type I and type II TGF-β receptors to inhibit TGF-β signaling. Tazat K; Hector-Greene M; Blobe GC; Henis YI Mol Biol Cell; 2015 Oct; 26(19):3535-45. PubMed ID: 26269580 [TBL] [Abstract][Full Text] [Related]
19. Functional antagonism of different G protein-coupled receptor kinases for beta-arrestin-mediated angiotensin II receptor signaling. Kim J; Ahn S; Ren XR; Whalen EJ; Reiter E; Wei H; Lefkowitz RJ Proc Natl Acad Sci U S A; 2005 Feb; 102(5):1442-7. PubMed ID: 15671181 [TBL] [Abstract][Full Text] [Related]
20. TGF-beta type II receptor phosphorylates PTH receptor to integrate bone remodelling signalling. Qiu T; Wu X; Zhang F; Clemens TL; Wan M; Cao X Nat Cell Biol; 2010 Mar; 12(3):224-34. PubMed ID: 20139972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]